Works matching IS 02724391 AND DT 1997 AND VI 40 AND IP 1

Results: 11

Pharmacological in vitro characterization of the arecoline bioisostere, Lu 25-109-T, a muscarinic compound with M1-agonistic and M2/M3-antagonistic properties.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 1, doi. 10.1002/(SICI)1098-2299(199701)40:1<1::AID-DDR1>3.0.CO;2-Q

By:

Meier, Eddi;
Frederiksen, Kristen;
Nielsen, Mogens;
Lembøl, Hanne Løve;
Pedersen, Henrik;
Hyttel, John

Publication type:

Article

Down-regulation of LPS-induced nitric oxide synthesis of murine macrophages by oral administration of Sho-saiko-to.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 48, doi. 10.1002/(SICI)1098-2299(199701)40:1<48::AID-DDR5>3.0.CO;2-T

By:

Izumi, Shigeru;
Ohno, Naohito;
Yadomae, Toshiro

Publication type:

Article

Prevention and/or treatment of ischemic stroke with nitric oxide synthase substrates.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 88, doi. 10.1002/(SICI)1098-2299(199701)40:1<88::AID-DDR9>3.0.CO;2-P

By:

Chiou, George C.Y.;
Hong, Show-Jen

Publication type:

Article

Erratum: Sheardown MJ, Knutsen LJS (1996): Unexpected neuroprotection observed with the adenosine A2A receptor agonist CGS 21680. Drug Dev Res 39:108-114.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 99, doi. 10.1002/(SICI)1098-2299(199701)40:1<99::AID-DDR11>3.0.CO;2-C

By:

Sheardown, Malcolm J.;
Knutsen, Lars J.S.

Publication type:

Article

Screening for inhibitors of the HMG-CoA reductase promoter in HepG2 cells: Identification of four non-oxysterol inhibitors.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 41, doi. 10.1002/(SICI)1098-2299(199701)40:1<41::AID-DDR4>3.0.CO;2-T

By:

Yagi, Yoshihiko;
Bevis, Debra J.;
Hart, Karen L.;
Hess, Gerard F.;
Dinh, Dac M.;
Keiser, Barbara J.;
Larsen, Scott D.;
Spilman, Charles H.

Publication type:

Article

Subchronic toxicity and reversibility of WR6026 dihydrochloride, an 8-aminoquinoline antileishmanial drug, in rats and dogs.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 75, doi. 10.1002/(SICI)1098-2299(199701)40:1<75::AID-DDR8>3.0.CO;2-Q

By:

Levine, Barry S.;
Furedi-Machacek, E. Marianna;
Brown, Alan P.;
Tomlinson, Michael J.

Publication type:

Article

Electrophysiological effects of Gallanilide on cardiac ventricular and Purkinje fibers.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 94, doi. 10.1002/(SICI)1098-2299(199701)40:1<94::AID-DDR10>3.0.CO;2-H

By:

Shang-Zhong, Xu;
Xin-Ying, Zhu;
Shou-Qi, Yan

Publication type:

Article

Binding of [125I] AB-MECA to the human cloned adenosine A3 receptor using the semliki forest virus expression system.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 35, doi. 10.1002/(SICI)1098-2299(199701)40:1<35::AID-DDR3>3.0.CO;2-U

By:

Patel, M.;
Harris, C.;
Lundstrom, K.

Publication type:

Article

Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 68, doi. 10.1002/(SICI)1098-2299(199701)40:1<68::AID-DDR7>3.0.CO;2-R

By:

Rapin, Jean R.;
Yoa, René G.;
Bouvier, Christine;
Drieu, Katy

Publication type:

Article

Pharmacological profile of LY301317, a potent and selective 5-HT1A agonist.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 17, doi. 10.1002/(SICI)1098-2299(199701)40:1<17::AID-DDR2>3.0.CO;2-W

By:

Wolff, Mary C.;
Benvenga, Mark J.;
Calligaro, David O.;
Fuller, Ray W.;
Gidda, Jaswant S.;
Hemrick-Luecke, Susan;
Lucot, James B.;
Nelson, David L.;
Overshiner, Carl D.;
Leander, J. David

Publication type:

Article

Percutaneous absorption and skin erythema: Quantification of capsaicin and its synthetic derivatives from gels incorporated with benzalkonium chloride by using non-invasive bioengineering methods.

Published in:

Drug Development Research, 1997, v. 40, n. 1, p. 56, doi. 10.1002/(SICI)1098-2299(199701)40:1<56::AID-DDR6>3.0.CO;2-S

By:

Fang, Jia-You;
Tsai, Ming-Jun;
Huang, Yaw-Bin;
Wu, Pao-Chu;
Tsai, Yi-Hung

Publication type:

Article

Works matching IS 02724391 AND DT 1997 AND VI 40 AND IP 1

Pharmacological in vitro characterization of the arecoline bioisostere, Lu 25-109-T, a muscarinic compound with M<sub>1</sub>-agonistic and M<sub>2</sub>/M<sub>3</sub>-antagonistic properties.

Down-regulation of LPS-induced nitric oxide synthesis of murine macrophages by oral administration of Sho-saiko-to.

Prevention and/or treatment of ischemic stroke with nitric oxide synthase substrates.

Erratum: Sheardown MJ, Knutsen LJS (1996): Unexpected neuroprotection observed with the adenosine A<sub>2A</sub> receptor agonist CGS 21680. Drug Dev Res 39:108-114.

Screening for inhibitors of the HMG-CoA reductase promoter in HepG2 cells: Identification of four non-oxysterol inhibitors.

Subchronic toxicity and reversibility of WR6026 dihydrochloride, an 8-aminoquinoline antileishmanial drug, in rats and dogs.

Electrophysiological effects of Gallanilide on cardiac ventricular and Purkinje fibers.

Binding of [<sup>125</sup>I] AB-MECA to the human cloned adenosine A<sub>3</sub> receptor using the semliki forest virus expression system.

Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat.

Pharmacological profile of LY301317, a potent and selective 5-HT<sub>1A</sub> agonist.

Percutaneous absorption and skin erythema: Quantification of capsaicin and its synthetic derivatives from gels incorporated with benzalkonium chloride by using non-invasive bioengineering methods.